mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation

Feng Hong1, Michelle D Larrea, Cheryl Doughty

  • 1Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.

Molecular Cell
|June 24, 2008
PubMed

Insights

The mechanistic target of rapamycin complex 1 (mTORC1) phosphorylates serum- and glucocorticoid-induced kinase 1 (SGK1) to control cell cycle progression. This pathway is implicated in cancer by regulating p27 protein localization.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The precise role of mTORC1 in cell cycle regulation remains incompletely understood.
  • mTORC1 is a key regulator of cell growth, proliferation, and metabolism.
  • Dysregulation of cell cycle control is a hallmark of cancer.

Purpose of the Study:

  • To elucidate the role of mTORC1 in regulating cell cycle progression.
  • To identify downstream targets of mTORC1 involved in cell cycle control.
  • To investigate the mechanism by which mTORC1 influences p27 function.

Main Methods:

  • Utilized cell culture models with controlled mTORC1 activation and inhibition.
  • Employed shRNA to deplete specific proteins like TSC2, raptor, and SGK1.
  • Performed Western blotting to assess protein phosphorylation and localization.
  • Conducted in vitro kinase assays to confirm direct phosphorylation events.

Main Results:

  • mTORC1 activation led to the phosphorylation and activation of SGK1 and p27 at T157.
  • Inhibition of mTORC1 or SGK1 reversed these phosphorylation events.
  • mTORC1 overexpression caused p27 mislocalization to the cytoplasm, conferring TGF-beta resistance.
  • Direct phosphorylation of SGK1 by mTOR and p27 by SGK1 was demonstrated in vitro.
  • mTORC1, raptor, and SGK1 form functional complexes within cells.

Conclusions:

  • SGK1 is a direct substrate of mTORC1, mediating its effects on p27.
  • mTORC1 promotes G1 phase progression partly via SGK1 activation.
  • Aberrant mTORC1 signaling contributes to cancer by deregulating the cell cycle through SGK1-mediated p27 phosphorylation and mislocalization.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...